Sienna Biopharmaceuticals, Inc.
SEC CIK 1656328 · SNNA · last insider filing 2019-10-04
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Beddingfield III Frederick | Director · President & CEO | filed 2017 - 2019 |
| Fenton Dennis M | Director | filed 2017 - 2019 |
| More Robert J | Director | filed 2017 - 2019 |
| Leonard Keith R | Director | filed 2017 - 2019 |
| Burow Kristina | Director | filed 2017 - 2019 |
| Hindman James M. | Director | filed 2018 - 2019 |
| Harris Todd | Director · Head of Corporate Development | filed 2017 - 2019 |
| Nelsen Robert | Director | filed 2017 - 2019 |
| Mast Erle T | Director | filed 2017 - 2018 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Azoy Alexander | Chief Financial Officer | filed 2019 - 2019 |
| Lizzul Paul F. | Chief Medical Officer | filed 2017 - 2019 |
| Andrews Timothy K. | General Counsel & Secretary | filed 2017 - 2019 |
| Stroehmann Diane | See Remarks | filed 2017 - 2019 |
| Smither John W | Chief Financial Officer | filed 2018 - 2019 |
| Peterson Richard D | Chief Financial Officer | filed 2017 - 2017 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.